# OnCo record ctcae-grading (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/ctcae-grading/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "ctcae-grading" ;
  schema:name "CTCAE toxicity grading (grade 3-4 adverse events)"@en ;
  schema:alternateName "CTCAE"@en, "Common Terminology Criteria for Adverse Events"@en, "grade 3-4"@en, "grade 3–4"@en, "grade ≥3"@en, "grade 3 or higher"@en, "grade 3"@en, "grade 4"@en, "grade 5"@en, "grade 1-2"@en, "grade 2"@en, "high-grade toxicity"@en, "severe adverse events"@en, "adverse event"@en, "adverse events"@en, "serious adverse event"@en, "serious adverse events"@en, "SAE"@en, "SAEs"@en, "treatment-related adverse events"@en, "TRAE"@en, "TRAEs"@en, "TEAE"@en, "TEAEs"@en, "treatment-emergent"@en, "treatment-related death"@en, "treatment-related deaths"@en, "toxic death"@en, "safety signal"@en, "tolerability profile"@en, "safety signals"@en ;
  schema:description "The standard 1-to-5 scale doctors use to grade every side effect in a trial: 1 mild, 2 moderate, 3 severe or needing hospital care, 4 life-threatening, 5 death. 'Grade 3-4 events in 40% of patients' is the usual headline safety figure."@en ;
  schema:url <https://onco.cc/terms/ctcae-grading/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Common_Terminology_Criteria_for_Adverse_Events> ;
  schema:citation <https://en.wikipedia.org/wiki/Common_Terminology_Criteria_for_Adverse_Events> ;
  onco:related <https://onco.cc/terms/qol-pro/>, <https://onco.cc/terms/dose-limiting-toxicity/>, <https://onco.cc/terms/dose-modification/>, <https://onco.cc/terms/irae/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/> .